BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 29438525)

  • 1. Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies.
    Zenklusen I; Jongo S; Abdulla S; Ramadhani K; Lee Sim BK; Cardamone H; Flannery EL; Nguyen T; Fishbaugher M; Steel RWJ; Betz W; Carmago N; Mikolajczak S; Kappe SHI; Hoffman SL; Sack BK; Daubenberger C
    J Infect Dis; 2018 Apr; 217(10):1569-1578. PubMed ID: 29438525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Complement System Contributes to Functional Antibody-Mediated Responses Induced by Immunization with Plasmodium falciparum Malaria Sporozoites.
    Behet MC; Kurtovic L; van Gemert GJ; Haukes CM; Siebelink-Stoter R; Graumans W; van de Vegte-Bolmer MG; Scholzen A; Langereis JD; Diavatopoulos DA; Beeson JG; Sauerwein RW
    Infect Immun; 2018 Jul; 86(7):. PubMed ID: 29735521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing Global Health through Development and Clinical Trials Partnerships: A Randomized, Placebo-Controlled, Double-Blind Assessment of Safety, Tolerability, and Immunogenicity of PfSPZ Vaccine for Malaria in Healthy Equatoguinean Men.
    Olotu A; Urbano V; Hamad A; Eka M; Chemba M; Nyakarungu E; Raso J; Eburi E; Mandumbi DO; Hergott D; Maas CD; Ayekaba MO; Milang DN; Rivas MR; Schindler T; Embon OM; Ruben AJ; Saverino E; Abebe Y; Kc N; James ER; Murshedkar T; Manoj A; Chakravarty S; Li M; Adams M; Schwabe C; Segura JL; Daubenberger C; Tanner M; Richie TL; Billingsley PF; Lee Sim BK; Abdulla S; Hoffman SL
    Am J Trop Med Hyg; 2018 Jan; 98(1):308-318. PubMed ID: 29141739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine.
    Mordmüller B; Surat G; Lagler H; Chakravarty S; Ishizuka AS; Lalremruata A; Gmeiner M; Campo JJ; Esen M; Ruben AJ; Held J; Calle CL; Mengue JB; Gebru T; Ibáñez J; Sulyok M; James ER; Billingsley PF; Natasha KC; Manoj A; Murshedkar T; Gunasekera A; Eappen AG; Li T; Stafford RE; Li M; Felgner PL; Seder RA; Richie TL; Sim BK; Hoffman SL; Kremsner PG
    Nature; 2017 Feb; 542(7642):445-449. PubMed ID: 28199305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Differential Antibody and T-Cell Responses to the
    Jongo SA; Church LWP; Mtoro AT; Chakravarty S; Ruben AJ; Swanson PA; Kassim KR; Mpina M; Tumbo AM; Milando FA; Qassim M; Juma OA; Bakari BM; Simon B; James ER; Abebe Y; Kc N; Saverino E; Gondwe L; Studer F; Fink M; Cosi G; El-Khorazaty J; Styers D; Seder RA; Schindler T; Billingsley PF; Daubenberger C; Sim BKL; Tanner M; Richie TL; Abdulla S; Hoffman SL
    Am J Trop Med Hyg; 2019 Jun; 100(6):1433-1444. PubMed ID: 30994090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine.
    McCoy ME; Golden HE; Doll TA; Yang Y; Kaba SA; Zou X; Gerbasi VR; Burkhard P; Lanar DE
    Malar J; 2013 Apr; 12():136. PubMed ID: 23607541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial.
    Sulyok Z; Fendel R; Eder B; Lorenz FR; Kc N; Karnahl M; Lalremruata A; Nguyen TT; Held J; Adjadi FAC; Klockenbring T; Flügge J; Woldearegai TG; Lamsfus Calle C; Ibáñez J; Rodi M; Egger-Adam D; Kreidenweiss A; Köhler C; Esen M; Sulyok M; Manoj A; Richie TL; Sim BKL; Hoffman SL; Mordmüller B; Kremsner PG
    Nat Commun; 2021 May; 12(1):2518. PubMed ID: 33947856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection.
    Scally SW; Murugan R; Bosch A; Triller G; Costa G; Mordmüller B; Kremsner PG; Sim BKL; Hoffman SL; Levashina EA; Wardemann H; Julien JP
    J Exp Med; 2018 Jan; 215(1):63-75. PubMed ID: 29167197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring immunological mechanisms of the whole sporozoite vaccination against P. falciparum malaria.
    Mo AX; Pesce J; Hall BF
    Vaccine; 2015 Jun; 33(25):2851-7. PubMed ID: 25917675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The whole parasite, pre-erythrocytic stage approach to malaria vaccine development: a review.
    Epstein JE; Richie TL
    Curr Opin Infect Dis; 2013 Oct; 26(5):420-8. PubMed ID: 23982233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live attenuated pre-erythrocytic malaria vaccines.
    Keitany GJ; Vignali M; Wang R
    Hum Vaccin Immunother; 2014; 10(10):2903-9. PubMed ID: 25483648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccine.
    Senkpeil L; Bhardwaj J; Little MR; Holla P; Upadhye A; Fusco EM; Swanson PA; Wiegand RE; Macklin MD; Bi K; Flynn BJ; Yamamoto A; Gaskin EL; Sather DN; Oblak AL; Simpson E; Gao H; Haining WN; Yates KB; Liu X; Murshedkar T; Richie TL; Sim BKL; Otieno K; Kariuki S; Xuei X; Liu Y; Polidoro RB; Hoffman SL; Oneko M; Steinhardt LC; Schmidt NW; Seder RA; Tran TM
    JCI Insight; 2024 Apr; 9(11):. PubMed ID: 38687615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection.
    Lyke KE; Ishizuka AS; Berry AA; Chakravarty S; DeZure A; Enama ME; James ER; Billingsley PF; Gunasekera A; Manoj A; Li M; Ruben AJ; Li T; Eappen AG; Stafford RE; Kc N; Murshedkar T; Mendoza FH; Gordon IJ; Zephir KL; Holman LA; Plummer SH; Hendel CS; Novik L; Costner PJ; Saunders JG; Berkowitz NM; Flynn BJ; Nason MC; Garver LS; Laurens MB; Plowe CV; Richie TL; Graham BS; Roederer M; Sim BK; Ledgerwood JE; Hoffman SL; Seder RA
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2711-2716. PubMed ID: 28223498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of human Pegivirus infections in whole Plasmodium falciparum sporozoite vaccination and controlled human malaria infection in African volunteers.
    Tumbo AM; Schindler T; Dangy JP; Orlova-Fink N; Bieri JR; Mpina M; Milando FA; Juma O; Hamad A; Nyakarungu E; Chemba M; Mtoro A; Ramadhan K; Olotu A; Makweba D; Mgaya S; Stuart K; Perreau M; Stapleton JT; Jongo S; Hoffman SL; Tanner M; Abdulla S; Daubenberger C
    Virol J; 2021 Jan; 18(1):28. PubMed ID: 33499880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adults.
    Jongo S; Church LWP; Milando F; Qassim M; Schindler T; Rashid M; Tumbo A; Nyaulingo G; Bakari BM; Athuman Mbaga T; Mohamed L; Kassimu K; Simon BS; Mpina M; Zaidi I; Duffy PE; Swanson PA; Seder R; Herman JD; Mendu M; Zur Y; Alter G; Kc N; Riyahi P; Abebe Y; Murshedkar T; James ER; Billingsley PF; Sim BKL; Richie TL; Daubenberger C; Abdulla S; Hoffman SL
    J Clin Invest; 2024 Jan; 134(6):. PubMed ID: 38194272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum.
    Behet MC; Foquet L; van Gemert GJ; Bijker EM; Meuleman P; Leroux-Roels G; Hermsen CC; Scholzen A; Sauerwein RW
    Malar J; 2014 Apr; 13():136. PubMed ID: 24708526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-selecting circumsporozoite protein-based malaria vaccine: A comparison of malaria sporozoite challenge model.
    Amelia F; Iyori M; Emran TB; Yamamoto DS; Genshi K; Otsuka H; Onoue Y; Yusuf Y; Islam A; Yoshida S
    Parasite Immunol; 2019 May; 41(5):e12624. PubMed ID: 30883819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody Feedback Limits the Expansion of B Cell Responses to Malaria Vaccination but Drives Diversification of the Humoral Response.
    McNamara HA; Idris AH; Sutton HJ; Vistein R; Flynn BJ; Cai Y; Wiehe K; Lyke KE; Chatterjee D; Kc N; Chakravarty S; Lee Sim BK; Hoffman SL; Bonsignori M; Seder RA; Cockburn IA
    Cell Host Microbe; 2020 Oct; 28(4):572-585.e7. PubMed ID: 32697938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines.
    Richie TL; Billingsley PF; Sim BK; James ER; Chakravarty S; Epstein JE; Lyke KE; Mordmüller B; Alonso P; Duffy PE; Doumbo OK; Sauerwein RW; Tanner M; Abdulla S; Kremsner PG; Seder RA; Hoffman SL
    Vaccine; 2015 Dec; 33(52):7452-61. PubMed ID: 26469720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria.
    Hoffman SL; Billingsley PF; James E; Richman A; Loyevsky M; Li T; Chakravarty S; Gunasekera A; Chattopadhyay R; Li M; Stafford R; Ahumada A; Epstein JE; Sedegah M; Reyes S; Richie TL; Lyke KE; Edelman R; Laurens MB; Plowe CV; Sim BK
    Hum Vaccin; 2010 Jan; 6(1):97-106. PubMed ID: 19946222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.